Khan Noman Ahmed Jang, Pacioles Toni, Alsharedi Mohamed
Hematology and Oncology, Joan C. Edwards School of Medicine at Marshall University, Huntington, USA.
Cureus. 2020 Jul 27;12(7):e9429. doi: 10.7759/cureus.9429.
Takotsubo cardiomyopathy (TC) also known as broken heart syndrome or stress-induced cardiomyopathy is a relatively rare and transient form of cardiomyopathy. It usually mimics myocardial infarction in terms of clinical and electrocardiographic presentation, but coronary angiography usually does not reveal any evidence of coronary artery occlusion. Even though many underlying causes including emotional, physical or physiological stress have been identified, the exact pathogenesis remains uncertain. Few of anticancer therapies have been reported as an emerging cause of TC; however, no strong evidence of immunotherapy causing cardiomyopathy. We here present a very rare case of atypical TC in a 57-year-old female with advanced stage non-small cell lung cancer who underwent combined cytotoxic chemotherapy and immunotherapy with carboplatin, pemetrexed and pembrolizumab.
应激性心肌病(TC)也被称为心碎综合征或应激性心肌病,是一种相对罕见的、短暂性的心肌病形式。它在临床和心电图表现上通常类似心肌梗死,但冠状动脉造影通常未发现任何冠状动脉闭塞的证据。尽管已经确定了包括情绪、身体或生理应激在内的许多潜在原因,但其确切发病机制仍不确定。很少有抗癌治疗被报道为TC的新出现原因;然而,没有强有力的证据表明免疫疗法会导致心肌病。我们在此报告一例非常罕见的非典型TC病例,患者为一名57岁晚期非小细胞肺癌女性,接受了卡铂、培美曲塞和帕博利珠单抗联合细胞毒性化疗和免疫治疗。